Immunomodulatory effects of atorvastatin on MRL/lpr mice.

Adv Rheumatol · 2022 · PMC9735199 · PMID 36471414

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

3 , compared with the vehicle group, the atorvastatin group and HCQ group had lower viability of splenic B cells, and we found that the viability of the atorvastatin group showed a trend of gradual decline over time.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.